Saltar al contenido
Merck
Todas las fotos(7)

Documentos clave

HPA047192

Sigma-Aldrich

Anti-CLCA2 antibody produced in rabbit

enhanced validation

Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

Sinónimos:

Anti-CLCRG2

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Código UNSPSC:
51111800
Atlas de proteínas humanas número:

origen biológico

rabbit

conjugado

unconjugated

forma del anticuerpo

affinity isolated antibody

tipo de anticuerpo

primary antibodies

clon

polyclonal

Línea del producto

Prestige Antibodies® Powered by Atlas Antibodies

Formulario

buffered aqueous glycerol solution

reactividad de especies

human

validación mejorada

orthogonal RNAseq
Learn more about Antibody Enhanced Validation

técnicas

immunofluorescence: 0.25-2 μg/mL
immunohistochemistry: 1:500-1:1000

secuencia del inmunógeno

EELTLSWTAPGEDFDQGQATSYEIRMSKSLQNIQDDFNNAILVNTSKRNPQQAGIREIFTFSPQISTNGPEHQPNGETHESHRIYVAIRAMDRNSLQSAVSNIAQAPLFIPPNSDPVPARDYLILKGVLTAMGL

Nº de acceso UniProt

Condiciones de envío

wet ice

temp. de almacenamiento

−20°C

modificación del objetivo postraduccional

unmodified

Información sobre el gen

human ... CLCA2(9635)

Descripción general

Calcium activated chloride channel 2(CLCA2) is an integral transmembrane protein. CLCA2 is induced during human mammary epithelial cell differentiation. CLCA2 is located on human chromosome 1p22.3.

Inmunógeno

chloride channel accessory 2

Aplicación

Anti-CLCA2 antibody has been used to detect CLCA2 in nasopharyngeal carcinoma(NPC) cell lines. It also has been used to detect CLCA2 in SiHa cells and tumor tissues using western blotting.

Acciones bioquímicas o fisiológicas

CLCA2 regulates cell migration and invasion and is also associated with p53 tumour suppressor genes. CCLA2 helps to maintain corneal transparency due to the high and tissue specific expression of CCLA2 gene in human corneal epithelium. CLCA2 plays an important role in suppressing breast cancer. CLCA2 is used as an effective immunohistochemical marker for distinguishing primary SCC and primary ADC of lungs.

Características y beneficios

Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:
  • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
  • Protein array of 364 human recombinant protein fragments.

Ligadura / enlace

Corresponding Antigen APREST71988

Forma física

Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Información legal

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

¿No encuentra el producto adecuado?  

Pruebe nuestro Herramienta de selección de productos.

Código de clase de almacenamiento

10 - Combustible liquids

Clase de riesgo para el agua (WGK)

WGK 1

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung
Shinmura,, et al.
Disease Markers, 2014 (2014)
Isolation and characterization of a Ca2+-activated chloride channel from human corneal epithelium
Itoh, Rei, et al.
Current Eye Research, 21(6), 918-925 (2000)
Yuan-Yuan Qiang et al.
Journal of experimental & clinical cancer research : CR, 37(1), 34-34 (2018-02-22)
CLCA2 was reported as a tumor suppressor and disregulated in breast cancer. However, its function in tumor growth and metastasis in NPC has rarely been reported. In this study, we investigated the functional and molecular mechanisms by which CLCA2 influences
CLCA2 interactor EVA1 is required for mammary epithelial cell differentiation
Ramena, G, et al.
PLoS ONE, 11(3), e0147489-e0147489 (2016)
CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer
Li, Xiuro, et al.
Oncogene, 23(7), 1474-1474 (2004)

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico